Explore engineered biology.
Track its applications.
From biological tools and therapeutic platforms to manufacturing, agriculture and environmental applications. Connect each technology to the evidence for its exact use.
Industry activity · Private operations
Sign in on EBIGRAPH to inspect current industry activity.
Reference directory · Eight companies and eight platforms or tools across four branches. Targeted private clinical discovery follows Moderna, Merck and one trial separately. Independent verification remains pending.
Follow the exact evidence
Keep technology identity, experimental findings, application performance, commercial availability and authorized uses in separate records. A product listing establishes availability only within its stated source scope. It does not establish performance or authorization.
Research claims retain the organism or sample, method, scale, measured result and limitations. Therapeutic studies retain their population, design and endpoints. Regulatory records retain the authority, jurisdiction, product, use and decision date.
Connected with Longevity & Health
Biotechnology follows enabling technologies and their broader applications. Longevity & Health follows aging, human health and tissue repair. Organizations and platforms can appear in both industries with one identity and separately sourced branch memberships.
Private intake & scope review
Inspect captured company sources and record a decision for the exact identity and scope. Scientific performance, clinical benefit and authorization need separate evidence.
Prepare a private intake batch
The initial adapter admits the directory targets once. A draft resolves shared identities but leaves source captures for you to complete. Existing targets remain available for review.
Clinical developments & source review · Private
Targeted discovery: Moderna and Merck company news plus the INTerpath-001 registry record. Other Biotechnology branches remain directory coverage. Checks run at 00:25 and 12:25 UTC.
Developments → · Source-date timeline → · Significance review →
Sign in on EBIGRAPH with reviewer access to inspect clinical sources.
Source support does not establish clinical benefit, approval or a breakthrough. Significance assessment remains pending.